ARCHIVES

Patient Groups Are Focus of New Alliances In a Shift of Cancer Advocacy Agenda

This article is from The Cancer Letter archive.

Vol. 22 No. 22 | May 31, 1996

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

April 29, 1988

Siemens To Provide Technology To DxTx For Lung Cancer Detection.

December 14, 2001

FDA Publishes Two Guidances for Lab-Developed Tests

October 3, 2014

In Brief: Wilson Names Director, MCW cancer Center; UAB Cancer Center Makes Three Appointments

February 9, 1996

Senate Report Calls For Review Of Progress In Cancer Program Restores Prevention And Control Funding

September 18, 1992

Appropriators Ask What Happens After NIH Budget-Doubling Ends In FY2004.

May 25, 2001